Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
1.810
+0.040 (2.26%)
Jan 14, 2025, 4:00 PM EST - Market closed
Longeveron Market Cap
Longeveron has a market cap or net worth of $26.85 million as of January 15, 2025. Its market cap has decreased by -23.05% in one year.
Market Cap
26.85M
Enterprise Value
5.68M
1-Year Change
-23.05%
Ranking
Category
Stock Price
$1.81
Market Cap Chart
Since the IPO on February 12, 2021, Longeveron's market cap has decreased from $172.48M to $26.85M, a decrease of -84.43%. That is a compound annual growth rate of -37.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 14, 2025 | 26.85M | 4.62% |
| Dec 31, 2024 | 25.67M | -24.83% |
| Dec 29, 2023 | 34.15M | -49.55% |
| Dec 30, 2022 | 67.68M | -72.36% |
| Dec 31, 2021 | 244.90M | 41.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 710.00B |
| UnitedHealth Group | 499.88B |
| Novo Nordisk | 385.14B |
| Johnson & Johnson | 344.07B |
| AbbVie | 312.91B |
| Merck & Co. | 254.63B |
| Thermo Fisher Scientific | 213.34B |
| AstraZeneca | 207.72B |